SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $117,563,000 | +46.9% | 680,307 | -2.3% | 0.03% | +47.6% |
Q4 2014 | $80,028,000 | -46.7% | 696,265 | -27.5% | 0.02% | -48.8% |
Q3 2014 | $150,069,000 | -68.8% | 960,514 | -75.4% | 0.04% | -36.9% |
Q2 2014 | $481,160,000 | +101.9% | 3,900,780 | +69.6% | 0.06% | 0.0% |
Q1 2014 | $238,311,000 | -18.0% | 2,300,077 | -28.8% | 0.06% | -19.8% |
Q4 2013 | $290,489,000 | -39.2% | 3,229,802 | -54.8% | 0.08% | +12.5% |
Q3 2013 | $477,450,000 | +114.0% | 7,138,912 | +111.7% | 0.07% | +2.9% |
Q2 2013 | $223,057,000 | – | 3,371,968 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |